Skip to main content

Table 4 Association between EQ-5D score, global health (VAS), and patient characteristics

From: Health-related quality of life in patients with rheumatoid arthritis

 

EQ-5D score

Global health (VAS)

Mean ± SD

P value

beta

SE

Mean ± SD

P value

beta

SE

Age

 ● >  60 years

0.86 ± 0.13

0.184

−0.016

0.012

7.8 ± 1.76

0.039

−3.260

1.571

 ● ≤ 60 years

0.88 ± 0.13

   

8.1 ± 1.62

   

Sex

 ● Woman

0.87 ± 0.14

0.244

−0.020

0.017

7.92 ± 1.7

0.681

−0.912

2.218

 ● Man

0.89 ± 0.11

   

8.01 ± 1.71

   

Smoking

 ● Yes

0.88 ± 0.11

0.566

0.012

0.021

8.08 ± 1.55

0.559

1.546

2.640

 ● No

0.87 ± 0.13

   

7.92 ± 1.71

   

Alcohol drinking

 ● Yes

0.87 ± 0.13

0.842

0.003

0.015

7.91 ± 1.6

0.826

−0.415

1.886

 ● No

0.87 ± 0.13

   

7.95 ± 1.73

   

Education

 ● <  6 years

0.86 ± 0.14

0.451

−0.010

0.013

7.71 ± 1.72

0.022

−3.711

1.619

 ● ≥ 6 years

0.87 ± 0.13

   

8.08 ± 1.67

   

Disease duration

 ● ≥ 10 years

0.86 ± 0.14

0.529

−0.008

0.012

7.83 ± 1.63

0.195

−2.044

1.576

 ● <  10 years

0.87 ± 0.12

   

8.04 ± 1.76

   

Unemployed or retired

 ● Yes

0.85 ± 0.14

0.019

−0.029

0.012

7.85 ± 1.71

0.316

−1.585

1.578

 ● No

0.88 ± 0.12

   

8.01 ± 1.68

   

DAS 28

 ● Non-remission (DAS28 > 2.6)

0.86 ± 0.13

<  0.001

−0.064

0.020

7.87 ± 1.73

0.017

−6.137

2.552

 ● Remission (DAS28 ≤ 2.6)

0.93 ± 0.10

   

8.49 ± 1.3

   

HAQ

 ● >  0.5

0.81 ± 0.15

<  0.001

−0.106

0.011

7.42 ± 1.8

<  0.001

−9.693

1.516

 ● ≤ 0.5

0.92 ± 0.09

   

8.39 ± 1.46

   

Rheumatoid factor

 ● Yes

0.87 ± 0.13

0.823

−0.003

0.014

7.9 ± 1.75

0.695

−0.732

1.866

 ● No

0.87 ± 0.14

   

7.97 ± 1.61

   

ACPA

 ● Yes

0.87 ± 0.13

0.323

−0.015

0.015

7.98 ± 1.68

0.645

0.887

1.926

 ● No

0.88 ± 0.13

   

7.89 ± 1.71

   

Hand or feet erosion

 ● Yes

0.86 ± 0.14

0.315

−0.018

0.017

7.88 ± 1.7

0.554

−1.308

2.208

 ● No

0.88 ± 0.11

   

8.01 ± 1.64

   

Diabetes mellitus

 ● Yes

0.89 ± 0.09

0.101

0.025

0.021

8.0 ± 2.04

0.784

0.725

2.641

 ● No

    

7.93 ± 1.66

   

Hypertension

 ● Yes

0.86 ± 0.14

0.294

−0.013

0.013

8.0. ± 1.74

0.498

1.088

1.607

 ● No

0.87 ± 0.13

   

7.89 ± 1.67

   

Dyslipidemia

 ● Yes

0.87 ± 0.13

0.801

0.003

0.013

8.1 ± 1.71

0.105

2.621

1.612

 ● No

0.87 ± 0.13

   

7.83 ± 1.69

   

Stroke

 ● Yes

0.89 ± 0.08

0.712

0.017

0.047

7.63 ± 2.49

0.601

−3.173

6.061

 ● No

0.87 ± 0.13

   

7.9.4 ± 1.68

   

Coronary artery disease

 ● Yes

0.79 ± 0.17

0.048

−0.077

0.039

7.46 ± 2.5

0.323

−4.912

4.967

 ● No

0.87 ± 0.13

   

7.95 ± 1.69

   

Depression

 ● Yes

0.74 ± 0.21

<  0.001

−0.138

0.021

6.78 ± 1.9

<  0.001

−12.608

2.783

 ● No

0.88 ± 0.12

   

8.04 ± 1.64

   

Anxiety

 ● Yes

0.73 ± 0.20

<  0.001

−0.154

0.020

6.83 ± 1.95

<  0.001

−12.248

2.661

 ● No

0.88 ± 0.11

   

8.05 ± 1.63

   
  1. Abbreviation:- EQ-5D EuroQol five dimensional questionnaire, VAS Visual analogue scale, DAS28 Disease activity score28, HAQ Health assessment questionnaire, ACPA anti-citrullinated peptide antibodies, SD standard deviation, SE standard error
Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us